Physician profile
Brandi P Wright
NPI 1073889408
$1,742.33
in general payments reported to CMS, 2019-2025
16 companies · $932 in 2025
The $932 reported for 2025 was more than what 76% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $48.41 · 2024: $762 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713 · Education: $29.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.84 |
| Education | $29.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $325.93 | 2024-2025 | Krystexxa, Tavneos |
| Ardelyx, INC. | $303.66 | 2024-2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $186.78 | 2024-2025 | Lokelma, Farxiga |
| Travere Therapeutics, INC. | $181.37 | 2024-2025 | Filspari |
| Mallinckrodt Hospital Products INC. | $172.80 | 2024-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $111.56 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.07 | 2023-2025 | |
| Ucb, INC. | $97.63 | 2024-2025 | Cimzia, Bimzelx |
| Novo Nordisk INC | $78.98 | 2025 | Rybelsus, Ozempic, Wegovy |
| Genentech USA, INC. | $36.05 | 2025 | Tecentriq |
| Glaxosmithkline, LLC. | $34.55 | 2024 | Benlysta |
| Akebia Therapeutics INC | $27.88 | 2025 | Vafseo |
| Vifor Pharma, INC. | $25.60 | 2025 | Veltassa |
| Janssen Biotech, INC. | $17.79 | 2025 | Tremfya |
| Viiv Healthcare Company | $16.20 | 2024 | Apretude |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandi Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.